Saturday, July 11, 2026

Drug profile · INN

oliceridine

oliceridine (OLINVYK) is a mu opioid receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — oliceridine
US status
approved
Class
Route
INTRAVENOUS
Patents
0
Programs
2
Data quality
0.84

Quick answer

oliceridine (OLINVYK) is a mu opioid receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN oliceridine
Brand OLINVYK
Mechanism Mu opioid receptor agonist
Target Mu-type opioid receptor
Route INTRAVENOUS
Formulation SOLUTION

Mechanism of action

Mu opioid receptor agonist

Primary target: Mu-type opioid receptor

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Low dose Oliceridine Approved · First People's Hospital · Oliceridine
  2. Oliceridine Unknown · Chinese Academy of · Hypoxemia During Surgery

Related & competitor drugs

  1. alvimopan Mu opioid receptor antagonist
  2. loperamide hydrochloride Mu opioid receptor agonist
  3. methadone hydrochloride Mu opioid receptor agonist
  4. morphine sulfate Mu opioid receptor agonist
  5. oxycodone Mu opioid receptor agonist
  6. oxycodone hydrochloride Mu opioid receptor agonist

Frequently asked questions

What is oliceridine?

oliceridine (OLINVYK) is a mu opioid receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for oliceridine?

OLINVYK is a marketed brand name for oliceridine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of oliceridine?

oliceridine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.